Wall Street brokerages expect ADMA Biologics Inc (NASDAQ:ADMA) to report sales of $10.29 million for the current quarter, according to Zacks. Four analysts have made estimates for ADMA Biologics’ earnings, with estimates ranging from $9.50 million to $10.90 million. ADMA Biologics posted sales of $6.56 million in the same quarter last year, which would indicate […]